跳至主要内容
临床试验/NL-OMON24484
NL-OMON24484尚未招募不适用

Bone augmentation with autologous adipose tissue-derived mesenchymal stem cells and calcium phosphate carriers in the human maxillary sinus floor elevation model

VU University medical center, De Boelelaan 1117, 1081 HV Amsterdam0 个研究点目标入组 15 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • minimal bone height of 4 mm at planned implant site(s)
  • - no local need for horizontal bone augmentation
  • - healthy appearance sinus maxillaris
  • - smoking below 10 sigarettes a day

排除标准

  • - History of malignancy or chronic infectious disease (i.e. HIV, Hepatitis)
  • - irradiation history in jaw area
  • - destructive sinus surgery indicated during anamnesis
  • - endocarditis or heart valve abnormalities, or heart valve prostheses
  • - abnormalities in the immune system, or use of immune suppressants
  • - severe bone metabolic disorders (e.g. severe osteoporosis treated with bisphosphonates)
  • - Chronic use (>7 consecutive days) of anticoagulants (such as aspirin) or Non-Steroidal Anti-Inflammatory
  • Drugs (NSAIDS) within 15 days prior to lipoaspriation
  • - Signs or symptoms of infection at the time of any surgical procedure
  • - pregnant or nursing, or intention to become pregnant

研究者

发起方
VU University medical center, De Boelelaan 1117, 1081 HV Amsterdam

相似试验